Plasma gelsolin and circulating actin correlate with hemodialysis mortality

Journal of the American Society of Nephrology

Volumn 20, Issue 5, 2009, Pages 1140-1148

  Lee, Po Shun ^a   Sampath, Kartik ^b   Karumanchi, S Ananth ^c   Tamez, Hector ^b   Bhan, Ishir ^b   Isakova, Tamara ^b   Gutierrez, Orlando M ^b   Wolf, Myles ^b   Chang, Yuchiao ^b   Stossel, Thomas P ^a   Thadhani, Ravi ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; GELSOLIN; BIOLOGICAL MARKER;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; KAPLAN MEIER METHOD; MULTICENTER STUDY; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; SURVIVAL; SURVIVOR; UNITED STATES;

ACTINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; GELSOLIN; HUMANS; KAPLAN-MEIERS ESTIMATE; REFERENCE VALUES; RENAL DIALYSIS; SURVIVAL ANALYSIS; SURVIVORS; UNITED STATES;

EID: 65649103459     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008091008     Document Type: Article

References (65)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-S119, 1998
2. Meyer TW, Hostetter TH: Uremia. N Engl J Med 357: 1316-1325, 2007
3. Naqvi SB, Collins AJ: Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 13: 199-204, 2006
4. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73: 391-398, 2008
5. Chertow GM: Modality-specific nutrition support in ESRD: Weighing the evidence. Am J Kidney Dis 33: 193-197, 1999
6. Mitch WE, Goldberg AL: Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897-1905, 1996
7. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1538, 2002
8. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38: 1251-1263, 2001 (Pubitemid 34193111)
9. Zoccali C, Mallamaci F, Tripepi G: Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl: S105-110, 2003 (Pubitemid 36605875)
10. Johansen KL, Young B, Kaysen GA, Chertow GM: Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80: 324-332, 2004 (Pubitemid 41080005)
11. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911, 1999 (Pubitemid 29197978)
12. Lee WM, Galbraith RM: The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326: 1335-1341, 1992
13. Goetzl EJ, Lee H, Azuma T, Stossel TP, Turck CW, Karliner JS: Gelsolin binding and cellular presentation of lysophosphatidic acid. J Biol Chem 275: 14573-14578, 2000 (Pubitemid 30339747)
14. Bucki R, Georges PC, Espinassous Q, Funaki M, Pastore JJ, Chaby R, Janmey PA: Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44: 9590-9597, 2005 (Pubitemid 40994353)
15. Osborn TM, Dahlgren C, Hartwig JH, Stossel TP: Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 292: C1323-C1330, 2007 (Pubitemid 46631726)
16. Yin HL, Stossel TP: Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 281: 583-586, 1979
17. Kwiatkowski DJ, Stossel TP, Orkin SH, Mole JE, Colten HR, Yin HL: Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 323: 455-458, 1986
18. Kwiatkowski DJ, Mehl R, Izumo S, Nadal-Ginard B, Yin HL: Muscle is the major source of plasma gelsolin. J Biol Chem 263: 8239-8243, 1988 (Pubitemid 18161532)
19. Suhler E, Lin W, Yin HL, Lee WM: Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 25: 594-598, 1997 (Pubitemid 27193970)
20. Mounzer KC, Moncure M, Smith YR, Dinubile MJ: Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 160: 1673-1681, 1999
21. DiNubile MJ, Stossel TP, Ljunghusen OC, Ferrara JL, Antin JH: Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation. Blood 100: 4367-4371, 2002
22. Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO: Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 243: 399-403, 2006
23. Heintzelman MB, Frankel SA, Artavanis-Tsakonas S, Mooseker MS: Cloning of a secretory gelsolin from Drosophila melanogaster. J Mol Biol 230: 709-716, 1993 (Pubitemid 23159916)
24. Christofidou-Solomidou M, Scherpereel A, Solomides CC, Christie JD, Stossel TP, Goelz S, DiNubile MJ: Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J Investig Med 50: 54-60, 2002 (Pubitemid 34098289)
25. Rothenbach PA, Dahl B, Schwartz JJ, O'Keefe GE, Yamamoto M, Lee WM, Horton JW, Yin HL, Turnage RH: Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 96: 25-31, 2004 (Pubitemid 38031978)
26. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP: Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 35: 849-855, 2007
27. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Jr, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007 (Pubitemid 47530570)
28. Erukhimov JA, Tang ZL, Johnson BA, Donahoe MP, Razzack JA, Gibson KF, Lee WM, Wasserloos KJ, Watkins SA, Pitt BR: Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells. Am J Respir Crit Care Med 162: 288-294, 2000
29. Janmey PA, Lind SE: Capacity of human serum to depolymerize actin filaments. Blood 70: 524-530, 1987
30. Weiner DJ, Bucki R, Janmey PA: The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am J Respir Cell Mol Biol 28: 738-745, 2003 (Pubitemid 36677178)
31. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 55: 1081-1090, 1999 (Pubitemid 29100722)
32. Ni XG, Zhou L, Wang GQ, Liu SM, Bai XF, Liu F, Peppelenbosch MP, Zhao P: The ubiquitin-proteasome pathway mediates gelsolin protein downregulation in pancreatic cancer. Mol Med 14: 582-589, 2008
33. McIntyre CW, Selby NM, Sigrist M, Pearce LE, Mercer TH, Naish PF: Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease. Nephrol Dial Transplant 21: 2210-2216, 2006 (Pubitemid 44295047)
34. Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, Levin NW, Yan G: Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis 42: 1200-1211, 2003 (Pubitemid 37486764)
35. Owen WF, Jr., Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993 (Pubitemid 23307908)
36. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan G: Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr 17: 372-380, 2007 (Pubitemid 47633467)
37. Semba RD, Ricks MO, Ferrucci L, Xue QL, Guralnik JM, Fried LP: Low serum selenium is associated with anemia among older adults in the United States. Eur J Clin Nutr 63: 93-99,
38. Mejean C, Roustan C, Benyamin Y: Anti-actin antibodies. Detection and quantitation of total and skeletal muscle actin in human plasma using a competitive ELISA. J Immunol Methods 99: 129-135, 1987 (Pubitemid 17089984)
39. Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, Tagle R, Gonzalez F, Quiroga T, Caceres MS, Leighton F, Pereira J: Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60: 1844-1850, 2001 (Pubitemid 32999989)
40. Mezzano D, Tagle R, Pais E, Panes O, Perez M, Downey P, Munoz B, Aranda E, Barja P, Thambo S, Gonzalez F, Mezzano S, Pereira J: Endothelial cell markers in chronic uremia: Relationship with hemostatic defects and severity of renal failure. Thromb Res 88: 465-472, 1997 (Pubitemid 28219053)
41. U.S. Renal Data System 2006 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
42. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T: Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1: 461-463, 1989 (Pubitemid 19063530)
43. Hsueh WA, Anderson PW: Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 20: 253-263, 1992
44. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005 (Pubitemid 41549902)
45. Lazarus JM, Owen WF: Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 24: 1019-1032, 1994
46. Yamamoto H, Ito H, Nakamura H, Hayashi E, Kishimoto S, Hashimoto T, Tagawa K: Human plasma gelsolin binds adenosine triphosphate. J Biochem 108: 505-506, 1990 (Pubitemid 20336653)
47. Lind SE, Janmey PA: Human plasma gelsolin binds to fibronectin. J Biol Chem 259: 13262-13266, 1984
48. Haddad JG, Harper KD, Guoth M, Pietra GG, Sanger JW: Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci U S A 87: 1381-1385, 1990 (Pubitemid 20080312)
49. Walker TS, Tomlin KL, Worthen GS, Poch KR, Lieber JG, Saavedra MT, Fessler MB, Malcolm KC, Vasil ML, Nick JA: Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73: 3693-3701, 2005
50. Trautner BW, Darouiche RO: Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control 32: 177-183, 2004
51. Hsu CY, Vittinghoff E, Lin F, Shlipak MG: The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141: 95-101, 2004 (Pubitemid 38937830)
52. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
53. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Camargo CA Jr, Melamed M, Norris K, Stampfer M, Powe NR, Thadhani R: Impact of activated vitamin D and race on hemodialysis survival. J Am Soc Nephrol 19: 1379-1388, 2008
54. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349: 446-456, 2003 (Pubitemid 36910023)
55. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr., Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005 (Pubitemid 41710323)
56. Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M: Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16: 2205-2215, 2005 (Pubitemid 41716454)
57. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483, 2006 (Pubitemid 43855050)
58. Kouyama T, Mihashi K: Fluorimetry study of N-(1-pyrenyl)iodoacetamide- labelled F-actin. Local structural change of actin protomer both on polymerization and on binding of heavy meromyosin. Eur J Biochem 114: 33-38, 1981 (Pubitemid 11101489)
59. Dahl B, Schiodt FV, Ott P, Gvozdenovic R, Yin HL, Lee WM: Plasma gelsolin is reduced in trauma patients. Shock 12: 102-104, 1999
60. DiNubile M, Antin J, Bressler S, Stossel T, Ferrara J: Decreased gelsolin levels are associated with interstitial pneumonia after allogeneic BMT. Blood 92: 683a, 1998
61. Ito H, Kambe H, Kimura Y, Nakamura H, Hayashi E, Kishimoto T, Kishimoto S, Yamamoto H: Depression of plasma gelsolin level during acute liver injury. Gastroenterology 102: 1686-1692, 1992
62. Smith DB, Janmey PA, Herbert TJ, Lind SE: Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots. J Lab Clin Med 110: 189-195, 1987
63. Smith DB, Janmey PA, Sherwood JA, Howard RJ, Lind SE: Decreased plasma gelsolin levels in patients with Plasmodium falciparum malaria: A consequence of hemolysis? Blood 72: 214-218, 1988
64. Lind SE, Smith DB, Janmey PA, Stossel TP: Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am Rev Respir Dis 138: 429-434, 1988
65. Lofberg M, Paunio T, Tahtela R, Kiuru S, Somer H: Serum gelsolin and rhabdomyolysis. J Neurol Sci 157: 187-190, 1998a (Pubitemid 28218563)